Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-Retroviral Agent”

Showing 20 of 0 results

Not applicableStudy completedNCT00001131
What this trial is testing

Effectiveness of Interleukin-2 (IL-2) Plus Anti-HIV Therapy in HIV-Positive Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 42
Testing effectiveness (Phase 2)Study completedNCT00007202
What this trial is testing

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Early research (Phase 1)Study completedNCT00006325
What this trial is testing

Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableStudy completedNCT00006290
What this trial is testing

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Who this might be right for
HIV InfectionsLipodystrophy
National Institute of Allergy and Infectious Diseases (NIAID) 60
Not applicableEnded earlyNCT00006326
What this trial is testing

Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir

Who this might be right for
HIV Infections
Agouron Pharmaceuticals 60
Not applicableStudy completedNCT00002236
What this trial is testing

Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive Patients

Who this might be right for
HIV Infections
Pharmacia and Upjohn 32
Large-scale testing (Phase 3)Study completedNCT00002371
What this trial is testing

The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine

Who this might be right for
HIV Infections
Bristol-Myers Squibb 80
Not applicableStudy completedNCT00002411
What this trial is testing

A Comparison of Two Triple-Drug Combinations in Patients Who Have Never Been Treated With Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb
Testing effectiveness (Phase 2)UnknownNCT00017992
What this trial is testing

Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV

Who this might be right for
HIV Infections
Triangle Pharmaceuticals 100
Not applicableStudy completedNCT00006494
What this trial is testing

Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 14
Large-scale testing (Phase 3)Study completedNCT00002448
What this trial is testing

Compare the Effects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients

Who this might be right for
HIV Infections
Hoffmann-La Roche 40
Large-scale testing (Phase 3)Study completedNCT00002436
What this trial is testing

The Safety and Effectiveness of Three Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Taken AZT

Who this might be right for
HIV Infections
Glaxo Wellcome 325
Testing effectiveness (Phase 2)Study completedNCT00000909
What this trial is testing

Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Large-scale testing (Phase 3)Study completedNCT00000751
What this trial is testing

A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT)

Who this might be right for
HIV InfectionsPregnancy
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1,600
Testing effectiveness (Phase 2)Study completedNCT00001132
What this trial is testing

Effectiveness of the Early Addition of Abacavir to an Anti-HIV Drug Combination

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableStudy completedNCT00002203
What this trial is testing

Two Anti-HIV Drug Combinations

Who this might be right for
HIV Infections
Glaxo Wellcome
Testing effectiveness (Phase 2)Study completedNCT00000880
What this trial is testing

Test the Effect of Cyclosporine on the Immune System of Patients With Early HIV Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Not applicableStudy completedNCT00000892
What this trial is testing

Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 300
Testing effectiveness (Phase 2)Study completedNCT00001084
What this trial is testing

Three Treatment Combinations Using Zidovudine Plus Lamivudine Plus Indinavir in HIV-Infected Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 500
Testing effectiveness (Phase 2)UnknownNCT00002219
What this trial is testing

Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children

Who this might be right for
HIV Infections
Gilead Sciences 36
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation